Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Research Article

Network Pharmacology and Experimental Verification of Si Shen Decoction Regulating FABP4/PPARγ/NFκB Pathway in the Treatment of Collagen-induced Arthritis

Author(s): Rui Guan, Jiashu Yao, Qing Qi, Jing Yu, Ruoshi Liu and Mingli Gao*

Volume 28, Issue 5, 2025

Published on: 03 April, 2024

Page: [872 - 882] Pages: 11

DOI: 10.2174/0113862073296957240312090935

Price: $65

Abstract

Aim: This study aimed to investigate the mechanism of Si Shen Decoction (SSD) in rats with Collagen-Induced Arthritis (CIA).

Background: Rheumatoid arthritis (RA) is a complex immune disease characterized by bilateral symmetrical multi-joint pain and swelling. SSD has shown good results in treating RA in clinical applications, but its mechanism of action remains unclear.

Objective: To investigate the mechanism of SSD in rats with Collagen-Induced Arthritis (CIA).

Methods: Bioinformatics and network pharmacology analyses were used to predict the possible treatment targets and signaling pathways. Elisa, Western blotting, and quantitative real-time polymerase chain reaction were used to verify the mechanism of SSD in the treatment of RA.

Results: FABP4, MMP9, and PTGS2 were the most common predicted therapeutic targets. SSD treatment significantly reduced synovitis, ankle swelling and bone erosion in CIA rats. The SSD group also significantly reduced the serum secretion of CRP, TNFα, and IL1β, decreased mRNA levels of FABP4, IKKα, and p65 in the synovial membrane, but increased PPARγ. Western blot showed that SSD treatment could significantly reduce the expression of FABP4, IKKα, and phosphorylated p65 (p-p65) proteins in the synovium. SSD was found to inhibit the FABP4/PPARγ/NFκB signaling pathway and reduce the inflammatory response in CIA rats. The therapeutic effect of SSD was significant with the increase of dose.

Conclusion: SSD can relieve joint symptoms in CIA rats and alleviate inflammation by inhibiting the FABP4/PPARγ/NFκB signaling pathway. The effect of high-dose SSD was more prominent.

Keywords: Si Shen decoction, rheumatoid arthritis, FABP4, NFκB signaling pathway, network pharmacology, collageninduced arthritis.

Graphical Abstract
[1]
Venetsanopoulou, A.I.; Alamanos, Y.; Voulgari, P.V.; Drosos, A.A. Epidemiology of rheumatoid arthritis: Genetic and environmental influences. Expert Rev. Clin. Immunol., 2022, 18(9), 923-931.
[http://dx.doi.org/10.1080/1744666X.2022.2106970] [PMID: 35904251]
[2]
Zhou, Y.S.; Wang, X.R.; An, Y.; Li, C.; Zhang, X.Y.; Duan, T.J. A multicenter study of deformity and disability in rheumatoid arthritis patients in China. Chin J Rheumatol, 2013, 17(8), 526-532.
[3]
Prasad, P.; Verma, S. Surbhi; Ganguly, N.K.; Chaturvedi, V.; Mittal, S.A. Rheumatoid arthritis: Advances in treatment strategies. Mol. Cell. Biochem., 2023, 478(1), 69-88.
[http://dx.doi.org/10.1007/s11010-022-04492-3] [PMID: 35725992]
[4]
Yang, K.R.; Shu, R.; Xu, D.Y.; Zhang, Y.; Liu, H. Rheumatoid arthritis after treatment with glucocorticoid Discussion on TCM treatment. Rheum. Arth., 2013, 2(7), 58-59.
[5]
Sun, P.Y.; Gao, M.L. Clinical observation on yiqi yangyin tongluo formula for rheumatoid arthritis patients of deficiency of Qi and Yin Syndrome. Liaoning J. Tradit. Chin. Med., 2019, 46(7), 1431-1433.
[6]
Zhao, Y.Y.; Gao, M.L.; Wang, L.M.; Wang, E.L. Gao Mingli’s experience in treating rheumatoid arthritis by supplementing qi and nourishing yin. Chin Archi TCM, 2019, 37(6), 1440-1442.
[7]
Mateen, S.; Shahzad, S.; Ahmad, S.; Naeem, S.S.; Khalid, S.; Akhtar, K.; Rizvi, W.; Moin, S. Cinnamaldehyde and eugenol attenuates collagen induced arthritis via reduction of free radicals and pro-inflammatory cytokines. Phytomedicine, 2019, 53, 70-78.
[http://dx.doi.org/10.1016/j.phymed.2018.09.004] [PMID: 30668414]
[8]
Yan, M.; Yan, Y.; Zhang, Z.; Wang, G.; Shi, W.; Jiang, M.; Zhao, J.; Wu, X.; Zeng, H. The effect of triptolide combined with crocin on arthritis in mice: from side effect attenuation to therapy. Front. Pharmacol., 2022, 13, 908227.
[http://dx.doi.org/10.3389/fphar.2022.908227] [PMID: 35814255]
[9]
Luan, J.; Hu, Z.; Cheng, J.; Zhang, R.; Yang, P.; Guo, H.; Nan, G.; Guo, N.; Gou, X. Applicability and implementation of the collagen induced arthritis mouse model, including protocols. (Review) Exp. Ther. Med., 2021, 22(3), 939.
[http://dx.doi.org/10.3892/etm.2021.10371] [PMID: 34335888]
[10]
Smolen, J.S.; Aletaha, D.; McInnes, I.B. Rheumatoid arthritis. Lancet, 2016, 388(10055), 2023-2038.
[http://dx.doi.org/10.1016/S0140-6736(16)30173-8] [PMID: 27156434]
[11]
Doumen, M.; Pazmino, S.; Bertrand, D.; Westhovens, R.; Verschueren, P. Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity. Joint Bone Spine, 2023, 90(3), 105491.
[http://dx.doi.org/10.1016/j.jbspin.2022.105491] [PMID: 36410680]
[12]
Tachecí, I.; Bradna, P.; Douda, T.; Baštecká, D.; Kopáčová, M.; Rejchrt, S.; Bureš, J. NSAID-induced enteropathy in rheumatoid arthritis patients with chronic occult gastrointestinal bleeding: A prospective capsule endoscopy study. Gastroenterol. Res. Pract., 2013, 2013, 1-10.
[http://dx.doi.org/10.1155/2013/268382] [PMID: 24382953]
[13]
Cohen, S.; Curtis, J.R.; DeMasi, R.; Chen, Y.; Fan, H.; Soonasra, A.; Fleischmann, R. Worldwide, 3-Year, post-marketing surveillance experience with tofacitinib in rheumatoid arthritis. Rheumatol. Ther., 2018, 5(1), 283-291.
[http://dx.doi.org/10.1007/s40744-018-0097-3] [PMID: 29470834]
[14]
Lü, S.; Wang, Q.; Li, G.; Sun, S.; Guo, Y.; Kuang, H. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms. J. Ethnopharmacol., 2015, 176, 177-206.
[http://dx.doi.org/10.1016/j.jep.2015.10.010] [PMID: 26471289]
[15]
Duan, H.; Khan, G.J.; Shang, L.; Peng, H.; Hu, W.; Zhang, J.; Hua, J.; Cassandra, A.; Rashed, M.M.A.; Zhai, K. Computational pharmacology and bioinformatics to explore the potential mechanism of Schisandra against atherosclerosis. Food Chem. Toxicol., 2021, 150, 112058.
[http://dx.doi.org/10.1016/j.fct.2021.112058] [PMID: 33582168]
[16]
Wang, W.; Li, H.; Lv, J.; Khan, G.J.; Duan, H.; Zhu, J. Isodon suzhouensis determination of the anti-oxidative stress mechanism of leaves by employing bioinformatic and novel research technology. ACS Omega, 2023, 8(3), 3520-3529.
[http://dx.doi.org/10.1021/acsomega.2c07913] [PMID: 36713735]
[17]
Zhu, Y.; Ouyang, Z.; Du, H.; Wang, M.; Wang, J.; Sun, H.; Kong, L.; Xu, Q.; Ma, H.; Sun, Y. New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharm. Sin. B, 2022, 12(11), 4011-4039.
[http://dx.doi.org/10.1016/j.apsb.2022.08.022] [PMID: 36386472]
[18]
Fu, X.Y.; Huang, W.Y.; Wu, J.M. Clinical observation on the treatment of rheumatoid arthritis by Sishen Decoction combined with Western medicine. J. Sichuan Trad. Chi. Med., 2012, 6, 75-77.
[19]
Cao, W. Clinical observation of 50 cases of rheumatoid arthritis treated with Sishenjian. J. Beijing Uni. Trad. Chin. Med., 2008, 7, 490-498.
[20]
Schinocca, C.; Rizzo, C.; Fasano, S.; Grasso, G.; La Barbera, L.; Ciccia, F.; Guggino, G. Role of the IL-23/IL-17 pathway in rheumatic diseases: An overview. Front. Immunol., 2021, 12, 637829.
[http://dx.doi.org/10.3389/fimmu.2021.637829] [PMID: 33692806]
[21]
Meyer, A.; Parmar, P.J.; Shahrara, S. Significance of IL-7 and IL-7R in RA and autoimmunity. Autoimmun. Rev., 2022, 21(7), 103120.
[http://dx.doi.org/10.1016/j.autrev.2022.103120] [PMID: 35595051]
[22]
Luo, T.; Lu, Y.; Yan, S.; Xiao, X.; Rong, X.; Guo, J. Network pharmacology in research of Chinese medicine formula: Methodology, application and prospective. Chin. J. Integr. Med., 2020, 26(1), 72-80.
[http://dx.doi.org/10.1007/s11655-019-3064-0] [PMID: 30941682]
[23]
Jang, S.; Kwon, E.J.; Lee, J.J. Rheumatoid arthritis: Pathogenic roles of diverse immune cells. Int. J. Mol. Sci., 2022, 23(2), 905.
[http://dx.doi.org/10.3390/ijms23020905] [PMID: 35055087]
[24]
Pope, J.E.; Choy, E.H. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin. Arthritis Rheum., 2021, 51(1), 219-229.
[http://dx.doi.org/10.1016/j.semarthrit.2020.11.005] [PMID: 33385862]
[25]
Achudhan, D.; Liu, S.C.; Lin, Y.Y.; Huang, C.C.; Tsai, C.H.; Ko, C.Y.; Chiang, I.P.; Kuo, Y.H.; Tang, C.H. Antcin K inhibits TNF-α, IL-1β and IL-8 expression in synovial fibroblasts and ameliorates cartilage degradation: Implications for the treatment of rheumatoid arthritis. Front. Immunol., 2021, 12, 790925.
[http://dx.doi.org/10.3389/fimmu.2021.790925] [PMID: 34975889]
[26]
Yao, Z.; Getting, S.J.; Locke, I.C. Regulation of TNF-induced osteoclast differentiation. Cells, 2021, 11(1), 132.
[http://dx.doi.org/10.3390/cells11010132] [PMID: 35011694]
[27]
Zhang, H.; Liu, L.; Jiang, C.; Pan, K.; Deng, J.; Wan, C. MMP9 protects against LPS-induced inflammation in osteoblasts. Innate Immun., 2020, 26(4), 259-269.
[http://dx.doi.org/10.1177/1753425919887236] [PMID: 31726909]
[28]
de Bus, I.A.; America, A.H.P.; de Ruijter, N.C.A.; Lam, M.; van de Sande, J.W.; Poland, M.; Witkamp, R.F.; Zuilhof, H.; Balvers, M.G.J.; Albada, B. PUFA-Derived N -acylethanolamide probes identify peroxiredoxins and small gtpases as molecular targets in LPS-Stimulated RAW264.7 macrophages. ACS Chem. Biol., 2022, 17(8), 2054-2064.
[http://dx.doi.org/10.1021/acschembio.1c00355] [PMID: 35867905]
[29]
Nakano, R.; Kitanaka, T.; Namba, S.; Kitanaka, N.; Suwabe, Y.; Konno, T.; Yamazaki, J.; Nakayama, T.; Sugiya, H. Non-Transcriptional and translational function of canonical NF-κB signaling in activating ERK1/2 in IL-1β-induced COX-2 expression in synovial fibroblasts. Front. Immunol., 2020, 11, 579266.
[http://dx.doi.org/10.3389/fimmu.2020.579266] [PMID: 33117381]
[30]
Furuhashi, M. Fatty acid-binding protein 4 in cardiovascular and metabolic diseases. J. Atheroscler. Thromb., 2019, 26(3), 216-232.
[http://dx.doi.org/10.5551/jat.48710] [PMID: 30726793]
[31]
Li, B.; Hao, J.; Zeng, J.; Sauter, E.R. SnapShot: FABP functions. Cell, 2020, 182(4), 1066-1066.e1.
[http://dx.doi.org/10.1016/j.cell.2020.07.027] [PMID: 32822569]
[32]
Guo, D.; Lin, C.; Lu, Y.; Guan, H.; Qi, W.; Zhang, H.; Shao, Y.; Zeng, C.; Zhang, R.; Zhang, H.; Bai, X.; Cai, D. FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis. Bone Res., 2022, 10(1), 45.
[http://dx.doi.org/10.1038/s41413-022-00211-2] [PMID: 35729106]
[33]
Dou, H.X.; Wang, T.; Su, H.X.; Gao, D.D.; Xu, Y.C.; Li, Y.X.; Wang, H.Y. Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes. Endocrine, 2020, 67(3), 587-596.
[http://dx.doi.org/10.1007/s12020-019-02157-8] [PMID: 31845180]
[34]
Lai, H.C.; Chen, P.H.; Tang, C.H.; Chen, L.W. Dipeptidyl peptidase 4 stimulation induces adipogenesis-related gene expression of adipose stromal cells. Int. J. Mol. Sci., 2023, 24(22), 16101.
[http://dx.doi.org/10.3390/ijms242216101] [PMID: 38003291]
[35]
Liu, W.C.; Wu, C.W.; Fu, M.H.; Tain, Y.L.; Liang, C.K.; Hung, C.Y.; Chen, I.C.; Lee, Y.C.; Wu, C.Y.; Wu, K.L.H. Maternal high fructose-induced hippocampal neuroinflammation in the adult female offspring via PPARγ-NF-κB signaling. J. Nutr. Biochem., 2020, 81, 108378.
[http://dx.doi.org/10.1016/j.jnutbio.2020.108378] [PMID: 32330843]
[36]
Mao, H.; Han, B.; Li, H.; Tao, Y.; Wu, W. FABP4 knockdown suppresses inflammation, apoptosis and extracellular matrix degradation in IL-1β-induced chondrocytes by activating PPARγ to regulate the NF-κB signaling pathway. Mol. Med. Rep., 2021, 24(6), 855.
[http://dx.doi.org/10.3892/mmr.2021.12495] [PMID: 34651666]
[37]
Ju, Z.; Su, M.; Hong, J.; Kim, E.L.; Jung, J.H. Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition. Bioorg. Chem., 2020, 96, 103611.
[http://dx.doi.org/10.1016/j.bioorg.2020.103611] [PMID: 32007723]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy